|
【结 构 式】 
|
【药物名称】 【化学名称】1-O-[4-[3(R)-[3(S)-Acetoxy-3-(4-fluorophenyl)propyl]-1-(4-fluorophenyl)-4-oxoazetidin-2(S)-yl]phenyl]-2,3,4-tri-O-acetyl-beta-D-glucopyranuronic acid methyl ester 【CA登记号】 【 分 子 式 】C39H39F2NO13 【 分 子 量 】767.74138 |
【开发单位】Schering-Plough (Originator) 【药理作用】Lipoprotein Disorders, Treatment of , METABOLIC DRUGS |
合成路线1
By condensation of D-glucopyranuronic acid methyl ester (I) with (3R,4S)-3-[3-acetoxy-3-(4-fluorophenyl)propyl]-1-(4-fluorophenyl)-4-(4-hydroxyphenyl)azetidin-2-one (III) by means of Tms-OTf.
| 【1】 Taraporewala, I.B.; Kauffman, J.M.; Synthesis and structure activity relationships of anti-inflammatory 9,10-dihydro-9-oxo-2-acridine-alkanoic acids and 4-(2-carboxyphenyl)aminobenzenealkanoic acids. J Pharm Sci 1990, 79, 2, 173. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 42779 | methyl (2S,3R,4S,5R,6S)-3,4,5-tris(acetoxy)-6-hydroxytetrahydro-2H-pyran-2-carboxylate | C13H18O10 | 详情 | 详情 | |
| (II) | 42780 | (trimethylsilyl)[(2S,3R,4S,5R,6S)-3,4,5-tris(acetoxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-2-yl]oxonium trifluoromethanesulfonate | C17H27F3O13SSi | 详情 | 详情 | |
| (III) | 42152 | (1S)-1-(4-fluorophenyl)-3-[(2S,3R)-1-(4-fluorophenyl)-2-(4-hydroxyphenyl)-4-oxoazetidinyl]propyl acetate | C26H23F2NO4 | 详情 | 详情 |
Extended Information